PRESS RELEASE published on 11/04/2024 at 20:05, 5 months 25 days ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital Poxel publie le nombre d'actions et de droits de vote composant son capital social conformément aux obligations réglementaires. Consultez le détail sur leur site web Capital Social Actions AMF Informations Réglementées Poxel
BRIEF published on 10/11/2024 at 07:35, 6 months 19 days ago Poxel publie son document d'enregistrement universel 2023 Gouvernance D'Entreprise Rapport Financier Annuel Poxel Rapport RSE Document D'enregistrement 2023
BRIEF published on 10/11/2024 at 07:35, 6 months 19 days ago Poxel Releases 2023 Universal Registration Document Corporate Governance Annual Financial Report CSR Report Poxel 2023 Registration Document
PRESS RELEASE published on 10/11/2024 at 07:30, 6 months 19 days ago Rapports financiers et d'audit annuels / Modalités de mise à disposition du rapport financier annuel Poxel annonce la mise à disposition de son Document d'Enregistrement Universel 2023 auprès de l'AMF pour l'exercice clos au 31 décembre 2023, incluant rapports financiers et sociaux AMF Maladies Métaboliques Document D'Enregistrement Universel Traitements Innovants Poxel
PRESS RELEASE published on 10/11/2024 at 07:30, 6 months 19 days ago Annual financial and audit reports / Terms of availability of the annual financial report Poxel announces availability of the 2023 Universal Registration Document including financial and governance reports, now filed with the AMF AMF Biopharmaceutical Company Financial Report Universal Registration Document Poxel
BRIEF published on 10/03/2024 at 18:35, 6 months 26 days ago Poxel announces its financial and strategic results for 2023 Financial Results Biopharmaceutical TWYMEEG® Poxel OrbiMed
BRIEF published on 10/03/2024 at 18:35, 6 months 26 days ago Poxel annonce ses résultats financiers et stratégiques pour 2023 Résultats Financiers Biopharmaceutique TWYMEEG® Poxel OrbiMed
PRESS RELEASE published on 10/03/2024 at 18:30, 6 months 26 days ago Informations privilégiées / Communiqué sur comptes, résultats Poxel publie ses résultats financiers pour l'année 2023 et dresse un bilan de ses activités. Accord avec OrbiMed, webinaires de présentation et perspectives de croissance Résultats Financiers Croissance Webinaires Poxel OrbiMed
BRIEF published on 09/30/2024 at 07:35, 7 months ago Poxel obtient un financement non dilutif de 50 millions de dollars auprès d'OrbiMed Financement Non Dilutif TWYMEEG® Poxel Monétisation Des Redevances OrbiMed
BRIEF published on 09/30/2024 at 07:35, 7 months ago Poxel Secures $50M Non-Dilutive Financing from OrbiMed Non-dilutive Financing TWYMEEG® Poxel Royalty Monetization OrbiMed
Published on 04/30/2025 at 14:30, 22 minutes ago Trans Canada Gold Corp. to Sell Its 18.75 % Petroleum and Natural Gas Rights and Interest in the Non-performing 8-23-049-1 W4M GP Well Only, and the GP Petroleum Zone Rights Within the AMI to Its Working Interest Partners
Published on 04/30/2025 at 14:30, 22 minutes ago Inspire Veterinary Partners Celebrates Record Veterinary Hiring and the Appointment of Lynley Kees to Chief People Officer
Published on 04/30/2025 at 14:15, 37 minutes ago Proof-of-Concept Results Show Crofelemer Reduced Total Parenteral Nutrition in Patients with Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) by up to 27% and 12.5% - Potential to Modify Disease
Published on 04/30/2025 at 14:01, 51 minutes ago Tharimmune Appoints Clay Kahler and Gary Stetz to its Board of Directors
Published on 04/30/2025 at 14:00, 52 minutes ago GameSquare Media Announces New Partnership with Esports.gg
Published on 04/30/2025 at 14:30, 22 minutes ago General Assembly of the Critical Infrastructure Association of the Slovak Republic Sets Future Direction
Published on 04/30/2025 at 14:15, 37 minutes ago GEA Annual General Meeting approves dividend increase and re-elects three Supervisory Board members
Published on 04/30/2025 at 14:09, 42 minutes ago FamiCord AG continues growth course in 2024 after strong year-end business and stabilizes business development in home market Germany
Published on 04/30/2025 at 14:01, 51 minutes ago Nebius Group N.V. announces date of first quarter 2025 results and conference call
Published on 04/30/2025 at 14:00, 52 minutes ago VAZIVA SA: Invitation webinaire actionnaires individuels le mercredi 14 mai 2025 à 18h00 - Présentation des Résultats annuels 2024
Published on 04/30/2025 at 08:30, 6 hours 22 minutes ago Mise à disposition des documents préparatoires à l’Assemblée Générale mixte
Published on 04/29/2025 at 19:02, 19 hours 49 minutes ago LNA SANTE : Mise à disposition du document d'enregistrement universel 2024
Published on 04/29/2025 at 18:22, 20 hours 30 minutes ago BIO-INOX : RESULTATS ANNUELS 2024 : CHIFFRE D'AFFAIRES +16,4% - RESULTAT NET +75,1%
Published on 04/29/2025 at 18:12, 20 hours 40 minutes ago 250429 BENETEAU Avis de mise à disposition de documents
